|
| News: FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL |
The U.S. Food and Drug Administration approved Tecartus (brexucabtagene autoleucel), a cell-based gene therapy for treatment of adult patients diagnosed with mantle cell lymphoma (MCL) who have not responded to or who have relapsed following other kinds of treatment. Tecartus, a chimeric antigen receptor (CAR) T cell therapy, is the first cell-based gene therapy approved by the FDA for the treatment of MCL. “Tremendous progress has been made in the discovery of new therapies for debilitating diseases that are difficult to treat. This approval is yet another example of customized treatments that use a patient’s own immune system to help fight cancer, while using a scientific advance in this promising new area of medicine,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “We’re seeing continued advances in the field of gene therapy and remain committed to supporting innovation in this promising new area of medicine.”
Read more... |
| Conference: Bioproduction Summit on Advances in AAV for Gene Therapy & Protein Production |
| The virtual Bioproduction Summit, 21-22 September 2020, brings together hundreds of biotech professionals in the field of "AAV Gene Therapy & Therapeutic Protein Production" to share practical solutions for today’s industry challenges ranging from developing scalable platform processes to analytical development for consistent product quality. Use code GTN25 to receive 25% discount on individual tickets.
Two days of talks, exhibitions, networking and collaboration on the latest technological advances involving leading industry experts from:
• Established and emerging biotech companies in the US and globally
• Large and midsize pharmaceutical companies
• CROs and CDMOs ranging from small to larger size companies
• Reagents & equipment manufacturers.
Register now... |
| Conference: Patient Centric Cell Therapy Supply Chain Summit |
The inaugural Patient-Centric Cell Therapy Supply Chain Summit, 22-25 September 2020 in Boston, will gather senior Heads of Cell Therapy, Logistics and Supply Chain experts to share practical solutions in overcoming common logistics and supply chain challenges for organization's preparing for commercialization. The Summit will also focus on delivering practical knowledge on how to optimize and re-design your processes while ensuring that you have the right technologies and partners while creating and maintaining a patient-centric supply chain in the commercial world.
Register now... |
| Conference: Gamma Delta T Therapies Summit |
The inaugural Gamma Delta T Therapies Summit, 30 September 2020, is the only industry dedicated forum focused on furthering the understanding of γδ T cells, driving clinical proof of concept, and scaling up manufacturing to deliver off-the-shelf gamma delta T therapies for oncological indications.
Join us virtually with the key stakeholders from across pharma, biotech, and academia to discuss the precise mechanisms of γδ T cells, manufacturing considerations to ensure purity and quantity of cells, and the latest developments in γδ T therapies.
Register now... |
| Conference: Cell Series UK 2020 - 6th Annual Cell & Gene Therapy Manufacturing Congress |
| With knowledge-sharing & innovation in the manufacturing, regulation, and commercialisation of advanced therapies more critical than ever, hear from cell & gene therapy leaders targeting increasingly difficult disease areas. View agenda of the 6th Annual Cell & Gene Therapy Manufacturing, 6-7 October 2020.
Over 250 attendees from global pharmaceutical organisations, leading biotechs and internationally renowned academic institutions pioneering cell & gene therapy manufacturing will discuss and share knowledge over 20 presentations and case studies providing actionable insights to improve your manufacturing workflow and enable scale-up, automation and high quality. PLUS Interactive opportunities including:
• Panel Discussion: Successful Manufacturing of Gene Therapies
• Workshop: Aligning Clinical and Manufacturing Teams for Successful Advanced Therapy Development.
Register now... |
| Conference: CAR-TCR Cell & Gene Therapy Innovators Summit 2020 |
The Asia Pharma R&D Leaders Summit 2020, 15-16 Ocotber 2020 in Shanghai, will bring in fresh perspectives and establish an efficient platform to discuss about the Trends for Future Global Pharma R&D Revolution and Promoting China Innovation: Emerging Therapeutics Research Innovation and Effective Partnership Model; Promoting China Innovation and Regulatory Landscape; Cellular-Based Immunotherapies (CAR-T & TCR-T Cell Therapy, CAR-NK, TIL Therapy, iPSC-derived Cell Therapy & Gene-Edited Cell Therapies etc., ); AAV-Based Gene Therapy for Human Diseases and much more.
Register now... |
| Conference: Cell & Gene Therapy Research & Development Congress Asia 2020 |
The Cell & Gene Therapy Research & Development Congress Asia 2020, 20-21 October 2020 in Taipei, focuses on the advances being made in cell and gene therapies which have rapidly become an integral and vital component of modern medicine. With more than 30 presentations across two days, the Cell & Gene Therapy Research & Development Congress Asia will provide a platform for leading biopharma and biotech leaders, academicians and researchers to discuss topics on emerging advances in the field of cell and gene therapy, the regenerative potential of stem cells, application of T- cells and Cart-T in the field of immuno-oncology, novel gene-editing tools and delivery methods, vector development, regulatory approaches, ethical considerations and more.
Register now... |
| Conference: Allogeneic Cell Therapies Summit 2020 |
The virtual 2nd Allogeneic Cell Therapies Summit, 26-28 October 2020 is the only meeting completely focussed on advancing the development of off-the-shelf therapies by advancing cryopreservation techniques and decreasing cost through industrialized manufacturing. Network with 250 industry leaders to discuss novel genetic engineering techniques that overcome rejection and avoid GVHD to pave the way for further breakthroughs in patient treatment.”
Register now... |
| Conference: 4th Gene Therapy for Rare Disorders Europe |
| In the context of rapid gene therapy progress and mounting regulatory scrutiny, the virtual 2nd Annual Gene Therapy Analytical Development Summit, 26-28 October 2020, will unite large pharma and innovative biotechs to discuss the full and comprehensive range of analytical tools required to guarantee the consistency, quality and safety of gene therapy products.
Focused specifically on addressing the unique analytical challenges posed by gene therapy vectors, this technical scientific conference will unite the Analytical Development, QC, CMC, and Process Development leaders grappling with these challenges first-hand.
Incorporating tracks taking a deep dive into bioassays, molecular biology, and analytical chemistry, this is your opportunity to gain extensive technical information enabling you to solve the exact challenges you’re encountering. Enhance your existing analytical methods and explore innovative novel tools to support safe and effective gene therapy development.
Register now... |
| Conferences |
| - |
18 August 2020, 3rd annual Hemophilia Drug Development Summit - Gene Therapies, Online event |
| - |
18 - 20 August 2020, 2nd Annual Cell Engager Summit, Online event |
| - |
24 - 26 August 2020, Innate Killer Summit 2020, Online event |
| - |
24 - 26 August 2020, World Orphan Drug Congress USA, Online event |
| - |
24 - 28 August 2020, 12th annual Bioprocessing Summit, Online event |
| - |
31 August - 2 September 2020, Blood Brain Barrier Summit - Gene Therapy Delivery, Online event |
| - |
31 August - 4 September 2020, PEGS: The Essential Protein Engineering and Cell Therapy Summit - Cell and Gene Therapies, Online event |
| - |
1 - 3 September 2020, Gene Therapy Analytical Development Europe, Online event |
| - |
8 - 11 September 2020, 15th Annual World Advanced Therapies Congress, Online event |
| - |
14 - 17 September 2020, CAR-TCR Summit Digital Week, Online event |
| - |
15 - 17 September 2020, Bioanalytical strategies for Cell & Gene Therapies workshop, Lisbon, Portugal |
| - |
21 - 22 September 2020, Bioproduction Summit on Advances in AAV for Gene Therapy & Protein Production, San Francisco, CA |
| - |
22 - 24 September 2020, Advanced Therapies Manufacturing Strategy Summit, Online event |
| - |
22 - 25 September 2020, Patient Centric Cell Therapy Supply Chain Summit, Boston, MA |
| - |
23 - 25 September 2020, American Society of Gene & Cell Therapy (ASGCT) Policy Summit 2020, Online event |
| - |
30 September 2020, Gamma Delta T Therapies Summit, Online event |
| - |
1 – 3 October 2020, 2020 Cell Therapies and Immunotherapy Conference, Online event |
| - |
6 – 7 October 2020, Cell Series UK 2020 - 6th Annual Cell & Gene Therapy Manufacturing Congress, Online event |
| - |
15 - 16 October 2020, Global Cell and Gene Therapy Innovation Leaders Shanghai Forum - Asia Pharma R&D Leaders Summit 2020, Shanghai, China |
| - |
20 – 21 October 2020, Cell & Gene Therapy Research & Development Congress Asia 2020, Taipei, Taiwan |
| - |
26 - 27 October 2020, 2nd Annual Gene and Cell Therapy: Quality Developments to Commercialization Summit, Munich, Germany |
| - |
26 - 28 October 2020, Allogeneic Cell Therapies Summit 2020, Boston, MA |
| - |
26 - 28 October 2020, 4th Gene Therapy for Rare Disorders Europe, London, UK |
| - |
2 November 2020, Cell & Gene Therapy USA 2020 event, Online event |
| - |
3 - 4 November 2020, 6th Annual Biopharma Development and Production (BDP) Week - 2nd Annual Cell and Gene Therapy Manufacturing, Shanghai Hongqiao, China |
| - |
4 - 6 November 2020, 6th Annual Genome Editing congress, Online event |
| - |
30 November - 3 December 2020, 2nd Annual Gene Therapy Analytical Development, Philadelphia, PA |
| - |
1 - 3 December 2020, Cellular Immunotherapies for Solid Tumors Digital Summit, Online event |
| - |
1 - 3 December 2020, 3rd Neuromuscular Drug Development Summit - Gene Therapies, Online event |
| - |
8 - 10 December 2020, Gene Therapy for Neurological Disorders Summit, Boston, MA |
|
Read more... |
|
Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net, Zika Virus Net and Corona Virus Net.
|
| To unsubscribe from the Newsletter, please login and edit your subscription details, or {unsubscribe}unsubscribe direct{/unsubscribe}, or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}. |
|
